bioRxiv
High Capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of Lung Adenocarcinoma
Publication
, Preprint
Vinod, N; Hwang, D; Azam, S; Van Swearingen, A; Wayne, E; Fussell, S; Sokolsky-Papkov, M; Pecot, C; Kabanov, A
2019
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Vinod, N., Hwang, D., Azam, S., Van Swearingen, A., Wayne, E., Fussell, S., … Kabanov, A. (2019). High Capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of Lung Adenocarcinoma. bioRxiv. https://doi.org/10.1101/2019.12.12.874198
Vinod, Natasha, Duhyeong Hwang, Salma Azam, Amanda Van Swearingen, Elizabeth Wayne, Sloane Fussell, Marina Sokolsky-Papkov, Chad Pecot, and Alexander Kabanov. “High Capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of Lung Adenocarcinoma.” BioRxiv, 2019. https://doi.org/10.1101/2019.12.12.874198.
Vinod N, Hwang D, Azam S, Van Swearingen A, Wayne E, Fussell S, et al. High Capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of Lung Adenocarcinoma. bioRxiv. 2019.
Vinod, Natasha, et al. “High Capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of Lung Adenocarcinoma.” BioRxiv, 2019. Epmc, doi:10.1101/2019.12.12.874198.
Vinod N, Hwang D, Azam S, Van Swearingen A, Wayne E, Fussell S, Sokolsky-Papkov M, Pecot C, Kabanov A. High Capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of Lung Adenocarcinoma. bioRxiv. 2019.